Skip to main content
Smart Investors Daily
OF

NASDAQ · OFIX

Orthofix Medical Inc.

Healthcare · Medical - Devices

$9.81

Down-$0.10 (-1.01%)

Updated Oct 26, 2026, 5:11 PM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
622.51M
P/E ratio
-5.25
Dividend yield
0.00%
52-week range
$8.50 – $16.99
Volume
247.6K
Avg. volume
261.03K

Price performance · OFIX

OFIX price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

OFIX closed at $9.81 after 20 trading sessions, down 0.30% for the selected period.

Last close
$9.81
Period change
-0.30%
Period low
$9.00
Period high
$9.99
Daily close
View OHLC price history
OFIX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$9.92$9.99$9.67$9.81247.6K
Oct 22, 2026$9.79$10.0583$9.79$9.99336.77K
Oct 21, 2026$9.71$9.94$9.64$9.74604.96K
Oct 20, 2026$9.68$9.95$9.68$9.85335.29K
Oct 19, 2026$9.34$9.665$9.2848$9.59296.09K
Oct 16, 2026$9.64$9.81$9.335$9.38286.07K
Oct 15, 2026$9.42$9.7238$9.35$9.59317.97K
Oct 14, 2026$9.24$9.295$9.15$9.25292.2K
Oct 13, 2026$9.38$9.49$8.99$9.26483.73K
Oct 12, 2026$9.15$9.30$9.12$9.28336.22K
Oct 9, 2026$9.00$9.235$8.99$9.17314.18K
Oct 8, 2026$9.18$9.30$8.855$9.00588.1K
Oct 7, 2026$9.33$9.57$9.18$9.20394.37K
Oct 6, 2026$9.53$9.59$9.38$9.41392.83K
Oct 5, 2026$9.09$9.54$9.01$9.50634.62K
Oct 2, 2026$9.26$9.33$9.07$9.09319.19K
Oct 1, 2026$9.44$9.57$9.16$9.21525.35K
Sep 30, 2026$9.75$9.75$9.38$9.41588.03K
Sep 29, 2026$9.80$9.82$9.49$9.75433.76K
Sep 28, 2026$9.33$9.865$9.19$9.84438.1K

Latest OFIX news

The latest Smart Investors Daily articles mentioning OFIX.

OFIX research

Overview

Company profile and research snapshot.

Company profile

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$20.00
Implied upside
—
Analysts
—
OFIX recent ratings
DateFirmRatingTarget
Aug 10, 2026Canaccord GenuityBuy—
Jul 6, 2026Barrington ResearchOutperform—
May 22, 2026Canaccord GenuityBuy—
May 22, 2026StifelBuy—
May 22, 2026Barrington ResearchOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.